Compare VRAX & RKDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VRAX | RKDA |
|---|---|---|
| Founded | 2013 | 2002 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Agricultural Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1M | 1.1M |
| IPO Year | 2021 | 2015 |
| Metric | VRAX | RKDA |
|---|---|---|
| Price | $2.35 | $0.27 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 26.3K | ★ 1.4M |
| Earning Date | 11-20-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 66.92 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,858,000.00 |
| Revenue This Year | N/A | $58.50 |
| Revenue Next Year | N/A | $475.01 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.10 | $0.25 |
| 52 Week High | $13.19 | $6.71 |
| Indicator | VRAX | RKDA |
|---|---|---|
| Relative Strength Index (RSI) | 35.91 | 25.30 |
| Support Level | $2.15 | N/A |
| Resistance Level | $3.01 | $0.78 |
| Average True Range (ATR) | 0.18 | 0.06 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 19.05 | 4.65 |
Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on post-acute infection syndromes (PAIS) and related areas of chronic immune dysfunction. The company's principal development activities are centered on T cell-based in vitro diagnostics and immune profiling. The company's flagship product candidate, ViraxImmune, is an in-development T cell-based assay and immune profiling platform intended to support the assessment of immune dysfunction, initially in PAIS indications.
Arcadia Biosciences Inc is a company with science-based approaches to develop high value products and drive innovation in the consumer goods industry. The company has one operating and reportable segment, which derives revenue from the sale of Zola coconut water. The company's consumer brands in the food, beverage, and body care categories, and others. Its products include: Zola Coconut Water, and Agronomic Wheat Traits. Geographically, the company operates in United States, Argentina, India, and Canada. It derives maximum revenue from United States.